Cleveland BioLabs

Cleveland BioLabs

Cleveland BioLabs

Clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications, with a focus on oncology and tissue protection.
Founded
2003
Raised
$7.7M
Follow us
Alexa global traffic share
Latest funding
$4,200,000
Post-IPO equity - 2015
$3,500,000
Venture capital - 2014
Team Size
50+
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Cleveland BioLabs makes some noise.